inflammation, such as diabetics or ESRD patients, when administered at early stages of atherosclerosis. Finally, we believe that the appropriate form, dosage and route of administration are of major importance and are matters that need to be reevaluated with more selective criteria.
Bariatric surgery for diabetic nephropathy Sir, The letters to the editor by Canales et al. [1] and Ahmed et al. [2] comment on hyperoxaluria, the formation of kidney stones and the stabilization or improvement of renal function after bariatric surgery. Several recent articles should assuage these concerns. Hyperoxaluria occurs as a consequence of procedures that result in malabsorption (RYGB) but not with restrictive procedures (gastric banding and gastric sleeve) [3] . Additionally, renal cytokines were observed to improve shortly after surgery [4] , while patients with stage 3 renal failure experienced renal function improvement at 6-and 12-month intervals after bariatric surgery [5] .
A major concern for health care delivery, worldwide, is the prevalence of diabetic nephropathy which continues to accelerate as the epidemic of type 2 diabetes goes unchecked. The early recognition of diabetic nephropathy is frequently late, as tubulointerstitial injury often precedes the onset of significant glomerular disease. Regardless of the specific mechanisms involved with the genesis of kidney injury, bariatric surgery may provide an approach that limits the progression of diabetic nephropathy to ESRD.
Obesity may be associated with renal injury, however, severe abdominal obesity has been associated with increased renal venous pressure as well as increased plasma renin activity and aldosterone concentrations [6] . In men, obesity is often associated with diminished testosterone levels which allows for the preferential deposition of abdominal/visceral fat and a hypogonadal obesity cycle [7] . This location of adipose accumulation may provide an additional 'hydraulic effect' for elevating the intraabdominal pressure. Therefore, there is a reasonable possibility that the improvement of kidney function after bariatric surgery may, in part, be related to the reduction in renal venous pressure.
Studies will have to be performed to determine whether bariatric surgery can help stabilize renal function once injury is detected. This will require intervention early in the disease process, even for those patients who do not meet the current criteria for bariatric surgery. Conceptual adjustments will have to be made, as the indications for bariatric surgery will shift to renoprotective guidelines rather than to obesity metrics alone.
